Ypsomed Holding (Switzerland) Insiders
| YPSN Stock | CHF 367.50 2.50 0.68% |
Ypsomed Holding employs about 2 K people. The company is managed by 8 executives with a total tenure of roughly 4667 years, averaging almost 583.0 years of service per executive, having 250.0 employees per reported executive. Recap of Ypsomed Holding's management performance can provide insight into the venture performance.
| Ulrike Bauer Insider Chief Officer |
| Sebastien Delarive Insider Chief Officer |
Ypsomed |
Ypsomed Holding Management Team Effectiveness
The company has return on total asset (ROA) of 0.0308 % which means that it generated a profit of $0.0308 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0703 %, meaning that it generated $0.0703 on every $100 dollars invested by stockholders. Ypsomed Holding's management efficiency ratios could be used to measure how well Ypsomed Holding manages its routine affairs as well as how well it operates its assets and liabilities.The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08.
Ypsomed Holding AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Ypsomed Holding AG Price Series Summation is a cross summation of Ypsomed Holding price series and its benchmark/peer.
Ypsomed Holding Notable Stakeholders
A Ypsomed Holding stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ypsomed Holding often face trade-offs trying to please all of them. Ypsomed Holding's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ypsomed Holding's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ulrike Bauer | Chief Officer | Profile | |
| Sebastien Delarive | Chief Officer | Profile | |
| Beat Maurer | Chief Officer | Profile | |
| Simon Michel | CEO Board | Profile | |
| Frank Mengis | COO Operations | Profile | |
| Michael Zaugg | Chief Officer | Profile | |
| Thomas Kutt | Head Relations | Profile | |
| Niklaus Ramseier | Chief Officer | Profile |
About Ypsomed Holding Management Performance
The success or failure of an entity such as Ypsomed Holding AG often depends on how effective the management is. Ypsomed Holding management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ypsomed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ypsomed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. YPSOMED HLDG operates under Medical Devices classification in Switzerland and is traded on Switzerland Exchange. It employs 1522 people.
Please note, the imprecision that can be found in Ypsomed Holding's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ypsomed Holding AG. Check Ypsomed Holding's Beneish M Score to see the likelihood of Ypsomed Holding's management manipulating its earnings.
Ypsomed Holding Workforce Analysis
Traditionally, organizations such as Ypsomed Holding use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ypsomed Holding within its industry.Ypsomed Holding Manpower Efficiency
Return on Ypsomed Holding Manpower
| Revenue Per Employee | 232.4K | |
| Revenue Per Executive | 58.1M | |
| Net Income Per Employee | 11.6K | |
| Net Income Per Executive | 2.9M |
Additional Tools for Ypsomed Stock Analysis
When running Ypsomed Holding's price analysis, check to measure Ypsomed Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ypsomed Holding is operating at the current time. Most of Ypsomed Holding's value examination focuses on studying past and present price action to predict the probability of Ypsomed Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ypsomed Holding's price. Additionally, you may evaluate how the addition of Ypsomed Holding to your portfolios can decrease your overall portfolio volatility.